PPARG and colitis: Since FXR and PPARγ are nuclear receptors known to abrogate colitis (Ning et al, 2019), we employed a TR‐FRET‐based ligand displacement assay (FXR) (Fig EV2G) and a cell line reporter assay (PPARγ) (Fig EV2H).